Heptares Therapeutics is a pioneer in the discovery of new medicines targeting G-protein-coupled receptors (GPCRs), a super-family of proteins linked to many human diseases. By combining their expertise and technologies with AstraZeneca’s drug discovery capabilities, they hope to open up new treatment options for people suffering from pain of osteoarthritis, from inflammatory diseases or cancer.
Read the press release on the collaboration here.
Do you have a video you would like the sector to see? Contact us.